ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 901

Sensitivity of Dual-Energy CT, Ultrasound, and X-Ray for Pseudogout: A Pilot Study

Sara K. Tedeschi1, Daniel Solomon 2, Kathleen Vanni 3, Dong Suh 3 and Stacy Smith 4, 1Brigham and Women's Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, 2Brigham and Women´s Hospital, Div. of Rheumatology, Immunology and Allergy, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Calcium pyrophosphate dihydrate (CPPD), dual-energy CT and ultrasound, imaging techniques, pseudogout

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S102: Metabolic & Crystal Arthropathies I: Clinical (898–902)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Advanced imaging modalities such as ultrasound (US) and dual-energy CT (DECT) can help diagnose crystalline arthritis. DECT is a highly sensitive and specific modality to detect gout and has not been well studied in pseudogout. We compared the sensitivity of DECT, US, and x-ray (XR) in pseudogout.

Methods: We prospectively enrolled patients with crystal-proven pseudogout in a pilot study at a tertiary care center, 3/2018-11/2018. Eligible patients were 18 years old with acute monoarthritis, joint aspiration, and synovial fluid calcium pyrophosphate (CPP) crystals identified via polarized microscopy. Patients with both monosodium urate and CPP crystals were excluded. Subjects underwent DECT, US, and XR of the aspirated joint and a standardized joint (right wrist). A musculoskeletal radiologist interpreted all images; a rheumatologist trained in US additionally interpreted US images and consensus was reached for each scan. DECT images were post-processed using Siemens syngo.via software, applying color-coded overlay indicating volume and location of CPP deposits. DECT was defined as positive if color-coded overlay consistent with CPP was present. We excluded artifacts in nail beds, skin, motion or beam hardening, and deposits < 1 mm. We considered two volume thresholds (cm3) for a positive DECT scan after inspecting the data: >0.40 cm3 and >0.01 cm3. Ultrasound was defined as positive if hyperechoic deposits in hyaline cartilage, fibrocartilage, or tendon were observed. X-ray was defined as positive if chondrocalcinosis was observed in hyaline cartilage or fibrocartilage. We calculated the sensitivity of a positive scan in the aspirated joint (reference standard: synovial fluid CPP crystals) and prevalence in the standardized joint.

Results: Ten patients enrolled a mean (SD) of 17 (9) days after joint aspiration. Mean age was 73 (10) years and 40% were female. The knee was aspirated in 8/10 and the wrist was aspirated in 2/10. Six subjects received intra-articular steroids before enrollment. In the aspirated joint, sensitivity (95% confidence interval) was 90% (62-100%) for DECT volume >0.40 cm3, and 100% (74-100%) for DECT volume >0.01 cm3; 100% (74-100%) for US; and 70% (41-92%) for XR (Table 1). In the standardized joint, DECT was positive in 20% (4-49%) for volume >0.40 cm3, and 90% (62-100%) for volume >0.01 cm3.  XR chondrocalcinosis was present in 30% (9-59%) and US was positive in 80% (51-96%) of wrists. Representative images from an aspirated knee and wrist are presented in Figure 1.

Conclusion: DECT and US had high sensitivity for pseudogout using synovial fluid CPP crystal analysis as the reference standard. Larger studies testing the sensitivity and specificity of DECT in pseudogout vs. other types of arthritis and establishing a volume threshold are needed.


Table 1 2019.06.01


Figure 1 2019.05.27


Disclosure: S. Tedeschi, None; D. Solomon, AbbVie, 2, Abbvie, 2, Amgen, 2, AstraZeneca, 2, Corrona, 2, Genentech, 2, Janssen, 2, Lilly, 2, Pfizer, 2; K. Vanni, None; D. Suh, None; S. Smith, None.

To cite this abstract in AMA style:

Tedeschi S, Solomon D, Vanni K, Suh D, Smith S. Sensitivity of Dual-Energy CT, Ultrasound, and X-Ray for Pseudogout: A Pilot Study [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/sensitivity-of-dual-energy-ct-ultrasound-and-x-ray-for-pseudogout-a-pilot-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sensitivity-of-dual-energy-ct-ultrasound-and-x-ray-for-pseudogout-a-pilot-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology